Post-transcription modulation of the blood-brain barrier GLUT1 glucose transporter by brain-derived factors

  • Ruben J. Boado
Conference paper


Brain-derived peptides or factors in the brain-derived preparation Cerebrolysin® (CI, EBEWE, Austria) increase the expression of the blood-brain barrier (BBB) GLUT1 glucose transporter via mRNA stabilization. The post-transcriptional regulation of the BBB-GLUT1 gene is principally exerted by interaction of cis-regulatory elements located in the 3’- untranslated region of GLUT1 mRNA with cellular trans-acting factors (TAF). UV-cross linking and RNase T1 protection studies demonstrated the presence of 2 major GLUT1 RNA-TAF complexes named p88 (stabilizing) and the p44 (destabilizing). The p88 TAF was detected in cytosol of brain endothelial cultured cells (ECL) as a duplex of molecular weight of ~88kDa, which were defined A and B (high and low MW, respectively). CI markedly increased the abundance of the BBB-GLUT1 p88 TAF (complex B) in ECL cells, without changes in the levels of the p88 complex A. This was also confirmed by antisense oligomer displacement of the GLUT1 RNA-TAF complex formation. CI per se, did not bind to the GLUT1 mRNA, nor induced the expression of the destabilizing p44 TAF. Data presented here suggest that the increased stabilization of the GLUT1 transcript induced by CI is associated with augmented levels of the GLUT1 stabilizing p88 TAF.


Glucose Transporter GLUT1 Glucose Transporter GLUT1 mRNA Large Neutral Amino Acid Transporter Arbitrary Densitometric Unit 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Boado RJ (1995) Brain-derived peptides regulate the steady state levels and increase stability of the blood-brain barrier GLUT1 glucose transporter mRNA. Neurosci Lett 197: 179 – 182PubMedCrossRefGoogle Scholar
  2. Boado RJ (1998a) Modulation of blood-brain barrier GLUT1 glucose transporter gene expression by brain-derived peptides. J Neural Transm 53: 323 – 331Google Scholar
  3. Boado RJ (1998b) Brain-derived peptides increase blood-brain barrier GLUT1 glucose transporter gene expression via mRNA stabilization. Neurosci Lett 255: 147– 150Google Scholar
  4. Boado RJ, Pardridge WM (1990) Molecular cloning of the bovine blood-brain barrier glucose transporter cDNA and demonstration of phylogenetic conservation of the 5’-untranslated region. Mol Cell Neurosci 1: 224 – 232PubMedCrossRefGoogle Scholar
  5. Boado RJ, Pardridge WM (1993) Glucose deprivation causes post-transcriptional enhancement of brain capillary endothelial glucose transporter gene expression via GLUT1 mRNA stabilization. J Neurochem 60: 2290 – 2296PubMedCrossRefGoogle Scholar
  6. Boado RJ, Pardridge WM (1998) Ten nucleotide cis element in the 3’-untranslated region of the GLUT1 glucose transporter mRNA increases gene expression via mRNA stabilization. Mol Brain Res 59: 109 – 113PubMedCrossRefGoogle Scholar
  7. Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM (1999a) Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci USA 96: 12079 – 12084CrossRefGoogle Scholar
  8. Boado RJ, Wu D, Windisch M (1999b) In vivo upregulation of the blood-brain barrier GLUT1 glucose transporter by brain-derived peptides. Neurosci Res 34: 217 – 224CrossRefGoogle Scholar
  9. Burd CG, Dreyfuss G (1996) Conserved structures and diversity of functions of RNA- binding proteins. Science 265: 615 – 621CrossRefGoogle Scholar
  10. Duret L, Dorkeld F, Gautier C (1993) Strong conservation of non-coding sequences during vertebrates evolution: potential involvement in post-transcriptional regulation of gene expression. Nucl Acids Res 21: 2315 – 2322PubMedCrossRefGoogle Scholar
  11. Dwyer KJ, Boado RJ, Pardridge WM (1996) Cis-element/cytoplasmic protein interaction within the 32027-untranslated region of the GLUT1 glucose transporter mRNA. J Neurochem 66: 449 – 458PubMedCrossRefGoogle Scholar
  12. Hamilton BJ, Nichols RC, Tsukamoto H, Boado RJ, Pardridge WM, Rigby WFC (1999) hnRNP A2 and hnRNP L bind the 3’UTR of glucose transporter 1 mRNA and exist as a complex in vivo. Biochem Biophys Res Commun 261: 646–651Google Scholar
  13. Levy AP, Levy NS, Goldberg MA (1996) Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. J Biol Chem 271: 25492 – 25497PubMedCrossRefGoogle Scholar
  14. McGowan KM, Long SD, Pekala PH (1995) Glucose transporter gene expression: Regulation of transcription and mRNA stability. Pharmac Ther 66: 465 – 505CrossRefGoogle Scholar
  15. Pardridge WM, Boado RJ (1993) Molecular cloning and regulation of gene expression of blood-brain barrier glucose transporter. In: Pardridge WM (ed), The blood-brain barrier: cellular and molecular biology. Raven Press, NY, 395 – 440Google Scholar
  16. Stephens JM, Carter BZ, Pekala PH, Malter JS (1992) Tumor necrosis factor a-induced glucose transporter (GLUT-1) mRNA stabilization in 3T3-L1 preadipocytes. J Biol Chem 267: 8336 – 8341PubMedGoogle Scholar
  17. Tsukamoto H, Boado RJ, Pardridge WM (1996) Differential expression in glioblastoma multiforme and cerebral hemangioblastoma of cytoplasmic proteins that bind two different domains within the 3’-untranslated region of the human glucose transporter 1 messenger RNA. J Clin Invest 97: 2823 – 2832PubMedCrossRefGoogle Scholar
  18. Tsukamoto H, Hamada Y, Wu D, Boado RJ, Pardridge WM (1998) GLUT1 glucose transporter: differential gene transcription and mRNA binding to cytosolic and polysome proteins in brain and peripheral tissues. Mol Brain Res 58: 170 – 177PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2000

Authors and Affiliations

  • Ruben J. Boado
    • 1
  1. 1.Department of MedicineUCLA School of MedicineLos AnglesUSA

Personalised recommendations